Cephalon: seeking more legitimate patients for Provigil follow-on – Trading Markets (press release)

Cephalon: seeking more legitimate patients for Provigil follow-on
Trading Markets (press release), CA
Mar 20, 2009 (Datamonitor via COMTEX) — CEPH | Quote | Chart | News | PowerRating — As the follow-on product to sleep disorders drug Provigil, which is scheduled to lose patent US market exclusivity in October 2011, Nuvigil represents a key product

Comments are closed.